4/A
Changes in Ownership
BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-12-048073
Options or other derivatives
- Chief Executive Officer acquired 70,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Harel Adrian · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2012-08-01 | Grant or award : show line 1 in the form Stock Option (right to buy) | +70,000 | 70,000 | D |
Loading xslF345X03/v322323_4a.xml…